Oligodendroglioma
📧 Sign up to get email alerts when something new happens for Oligodendroglioma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-02-09Clinical Trial Update: A Phase II Study of Temozolomide and O6-Benzylguanine (O6-BG) in Patients With Temozolomide-Resistant Anaplastic Glioma [Phase 2]
This Phase II study evaluating temozolomide in combination with O6-benzylguanine for temozolomide-resistant anaplastic glioma was terminated…
-
CLINICAL_TRIALS trial_result · 2012-02-06Clinical Trial Update: Lapatinib in Treating Young Patients With Recurrent or Refractory Central Nervous System Tumors [Phase 1, Phase 2]
This clinical trial update summarizes the results of a Phase 1/2 study evaluating lapatinib in pediatric patients with recurrent or refracto…
-
CLINICAL_TRIALS trial_result · 2011-12-09Clinical Trial Update: Phase II Study of Irinotecan HCI for Recurrent Anaplastic Astrocytomas, Mixed Malignant Gliomas, and Oligodendrogliomas [Phase 2]
Phase II trial of irinotecan hydrochloride in recurrent anaplastic astrocytoma, mixed malignant glioma, and oligodendroglioma was terminated…
-
CLINICAL_TRIALS trial_result · 2011-07-11Clinical Trial Update: Gefitinib and Radiation Therapy in Treating Children With Newly Diagnosed Gliomas [Phase 1, Phase 2]
A pediatric Phase 1/2 trial evaluated gefitinib in combination with radiation therapy for newly diagnosed gliomas; the study completed and r…
-
CLINICAL_TRIALS trial_result · 2010-05-17Clinical Trial Update: The Effects of Continuous 28-day (28/28) Temozolomide Chemotherapy in Subjects With Recurrent Malignant Glioma Who Have Failed the Conventional 5-day (5/28) Treatment (P04601) [Phase 2]
Phase 2 trial evaluating continuous 28-day temozolomide in patients with recurrent malignant glioma who failed the standard 5-day regimen; r…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2009-11-02Clinical Trial Update: Prolonged Daily Temozolomide for Low-Grade Glioma [Phase 2]
Phase 2 trial results from Dana-Farber Cancer Institute evaluate prolonged daily temozolomide in patients with low-grade glioma, including a…
-
CLINICAL_TRIALS trial_result · 2009-04-03Clinical Trial Update: A Study of Motexafin Gadolinium and Temozolomide for the Treatment of Malignant Gliomas [Phase 1]
Phase 1 study evaluating the combination of motexafin gadolinium and temozolomide in malignant gliomas has completed.
-
CLINICAL_TRIALS trial_result · 2008-07-17Clinical Trial Update: Randomized Phase III Study of Sequential Radiochemotherapy of Anaplastic Glioma With PCV or Temozolomide [Phase 3]
Phase III randomized study comparing sequential radiochemotherapy with PCV (procarbazine, lomustine, vincristine) versus temozolomide in pat…